(Q38802883)

6 September 2017

title

Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies (English)

1 reference

6 September 2017

1 reference

3

C E Teunissen

1 reference

6 September 2017

A W Lemstra

1

1 reference

6 September 2017

M H de Beer

2

1 reference

6 September 2017

C Schreuder

4

1 reference

6 September 2017

P Scheltens

5

1 reference

6 September 2017

W M van der Flier

6

1 reference

6 September 2017

S A M Sikkes

7

1 reference

6 September 2017

language of work or name

English

0 references

publication date

28 October 2016

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

6 September 2017

published in

1 reference

6 September 2017

volume

88

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

113-118

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

6 September 2017

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Neuropathology underlying clinical variability in patients with synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

CSF markers for incipient Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

A comparison of anlaytic methods for non-random missingness of outcome data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Missing data in a multi-item instrument were best handled by multiple imputation at the item score level

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Longitudinal data analyses using linear mixed models in SPSS: concepts, procedures and illustrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Multimodality imaging characteristics of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Dementia with Lewy bodies: basis of cingulate island sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Tau pathology and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Incidence of dementia with Lewy bodies and Parkinson disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Imaging the role of amyloid in PD dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Challenges of multimorbidity of the aging brain: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2016-313775

21 January 2018

Identifiers

DOI

10.1136/JNNP-2016-313775

1 reference

6 September 2017

1 reference